Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Is there an optimal sequential order to androgen receptor axis therapeutics?
Journal: Clinical advances in hematology & oncology : H&O
Published: April 17, 2026
Loneliness within couples coping with cancer: prevalence, associations with physical and mental health, and potential benefits of dyadic exercise.
Journal: Frontiers in aging
Published: February 17, 2026
A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: December 22, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 23, 2025
Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey.
Journal: Cancer medicine
Published: August 11, 2025
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types.
Journal: Cancer research communications
Published: July 18, 2025
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial.
Journal: Nature medicine
Published: May 01, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 23, 2025
Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as Connection.
Journal: European urology oncology
Published: December 23, 2024
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 19, 2024
Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapy.
Journal: Journal of geriatric oncology
Published: July 22, 2024
Last Updated: 09/26/2026